Arch Capital Group Ltd.’s ACGL, Accident & Health business unit has announced the launch of a new Individual Supplemental Health product suite. Arch’s supplemental health products offer financial protection from medical costs not covered by primary insurance, such as deductibles and out-of-network charges. Designed for employees, gig workers, and independent contractors, the suite includes Accident Medical Expense, Hospital Indemnity, Critical Illness, and Accidental Death. Together, these benefits ensure financial support amid sudden medical expenses.
These products are portable and require no medical underwriting, making them suitable for individuals undergoing job or life changes. The APEX platform and API integration allow fast enrolment, backed by a licensed call center for partner and client support.
The supplemental health product suite supports financial growth of Arch by diversifying revenue streams and expanding into the individual insurance market. The product suite increases premium income, opens cross-selling opportunities across product lines, and enhances underwriting profitability. Additionally, the launch strengthens Arch’s brand and market position as a modern, flexible provider in the supplemental health space.
Aflac & MetLife Sharpen Competitive Edge With Bold Benefits Plays
Aflac Incorporated AFLhas launched an individual Accident Insurance plan across 32 U.S. states, providing cash benefits for covered incidents like ER visits, ambulance services, and therapy, including mental health. Aflac's updated offering expands post-accident care and preventive benefits, aiming to ease financial strain and support holistic recovery beyond what standard health insurance covers.
MetLife, Inc. MET expanded access to its Upwise platform via Workday Marketplace, offering personalized support for employees choosing Accident, Critical Illness, or Hospital Indemnity plans. This move simplifies benefits selection and boosts engagement in supplemental health products, positioning MetLife strongly in the voluntary benefits space.
ACGL’s Price Performance, Valuation & Estimates
Over the past year, ACGL’s shares have lost 10.6%, underperforming the industry and the Zacks S&P 500 Composite.
AJG’s YTD Price Performance
Image Source: Zacks Investment ResearchFrom a valuation standpoint, ACGL trades at a price-to-book ratio of 1.61, up from the industry average of 1.54. The company carries a Value Score of B.
Image Source: Zacks Investment ResearchThe Zacks Consensus Estimate for ACGL’s 2025 earnings implies a 15.30% decline year over year, followed by a 19.77% increase next year.
Image Source: Zacks Investment ResearchACGL stock currently carries a Zacks Rank #3 (Hold). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
MetLife, Inc. (MET): Free Stock Analysis Report Aflac Incorporated (AFL): Free Stock Analysis Report Arch Capital Group Ltd. (ACGL): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).
Zacks Investment Research